Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01228539 · ClinicalTrials.gov registry record · NA
Breaking the Cycle IV: Military PTSD (MPTSD) Treatment Study
A NA study, sponsored by UConn Health.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT01228539 is a NA study that has completed, run by UConn Health. The registered enrollment target is 31 participants.
The verdict
NCT01228539, a NA study, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
The study will compare the efficacy of Trauma Affect Regulation: Guide for Education and Therapy (TARGET) vs. the best validated psychotherapy for adults with posttraumatic stress disorder (PTSD), Prolonged Exposure (PE). Male military personnel and veterans suffering with PTSD and problems with anger after returning from military service in Afghanistan (Operation Emerging Freedom, OEF) and/or Iraq (Operation Iraqi Freedom, OIF) will be participants. The goal is to determine if a present-centered psychotherapy that teaches skills for emotion regulation and does not require re-telling of traumatic memories is as efficacious as the trauma memory-focused PE psychotherapy.
Interventions
- BEHAVIORAL Prolonged Exposure
- BEHAVIORAL TARGET (Trauma Affect Regulation)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2010-01 |
| Est. Completion | 2012-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01228539
The ClinicalTrials.gov registry entry for NCT01228539 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Prolonged Exposure is the first listed.
NCT01228539 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01228539 about?
NCT01228539 is a clinical study titled "Breaking the Cycle IV: Military PTSD (MPTSD) Treatment Study". The study will compare the efficacy of Trauma Affect Regulation: Guide for Education and Therapy (TARGET) vs. the best validated psychotherapy for adults with posttraumatic stress disorder (PTSD), Prolonged Exposure (PE). Male military personnel and veterans suffering with PTSD and problems with ang...
What is the current status of trial NCT01228539?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2010-01. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01228539?
The interventions under investigation include: Prolonged Exposure (BEHAVIORAL), TARGET (Trauma Affect Regulation) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01228539?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.